Back to Search
Start Over
Mutation of the MYL3 gene in a patient with mid-ventricular obstructive hypertrophic cardiomyopathy.
- Source :
-
BMJ case reports [BMJ Case Rep] 2022 Mar 14; Vol. 15 (3). Date of Electronic Publication: 2022 Mar 14. - Publication Year :
- 2022
-
Abstract
- In this study, we discuss a female patient referred to cardiology with left ventricular hypertrophy at mid-ventricular segments resulting in a mid-cavitary obstruction and a left ventricular apical aneurysm. The patient had normal epicardial coronary arteries, but presented with recurrent cerebrovascular events. The patient had a positive family history for sudden cardiac death. Cardiac MRI detected positive features of left ventricular mid-cavity obstruction, left ventricular apical aneurysm and delayed gadolinium enhancement, with Holter monitoring assessment displaying segments of non-sustained ventricular tachycardia. Genetic analysis detected an myosin light chain 3 ( MYL3 ) gene mutation. The patient will be referred to receive an implantable cardioverter defibrillator.The MYL3 gene mutation is a rare variant in patients with familial hypertrophic cardiomyopathy. To our knowledge, the presence of a left ventricular apical aneurysm has not been previously reported in literature concerning the MYL3 gene mutation. The presence of this abnormality further increases the risk of sudden cardiac death.<br />Competing Interests: Competing interests: None declared.<br /> (© BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.)
Details
- Language :
- English
- ISSN :
- 1757-790X
- Volume :
- 15
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- BMJ case reports
- Publication Type :
- Academic Journal
- Accession number :
- 35288424
- Full Text :
- https://doi.org/10.1136/bcr-2021-244573